Overview Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome Status: Completed Trial end date: 2019-11-18 Target enrollment: Participant gender: Summary The main purpose of this study is to establish whether RP101 can reduce symptoms of dry eye syndrome in post-menopausal women. Phase: Phase 2 Details Lead Sponsor: Redwood Pharma ABCollaborator: Cross Research S.A.Treatments: EstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valeratePolyestradiol phosphate